GreenLight Biosciences Rings the Nasdaq Stock Market Closing Bell
GreenLight Biosciences (Nasdaq: GRNA), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Dr. Andrey Zarur, CEO, rings the Closing Bell.